IL17A and Cerebral ischemia: Phospholipase A2 of PRDX6 can improve cerebral ischemia/reperfusion inflammatory injury by reducing the expression of the inflammatory cytokines IL-1β, IL-17, and IL-23 and oxidative stress30,31.